MEDIVATION INC | 37,13 Euro | -1,485 -3,85 % | |
| WKN: A0ETXH ISIN: US58501N1019 Ticker-Symbol: WMD | Stuttgart | 17.05.13 | 08:06 Uhr |
Branche BiotechnologieAktienmarkt NASDAQ Biotech |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 13.05. | Medivation Names Stephen Kelsey Senior Vice President of New Projects | 48 | Marketwired | |
| SAN FRANCISCO, CA -- (Marketwired) -- 05/13/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that Stephen M. Kelsey, M.D., F.R.C.P., F.R.C.Path. will join Medivation in the newly-created position... Mehr lesen zu: Medivation Names Stephen Kelsey Senior Vice President of New Projects | ||||
| 13.05. | Medivation Loss Narrower Than Expected | 1 | Zacks | |
| 13.05. | MEDIVATION, INC. - 8-K, Current Report | 1 | SEC Filings | |
| 10.05. | Medivation Management Discusses Q1 2013 Results - Earnings Call Transcript | 5 | Seeking Alpha | |
| 09.05. | Medivation, Inc. (MDVN) Tops Q1 EPS by 5c; Names Directors | 3 | StreetInsider.com | |
| 09.05. | Medivation Reports First Quarter Financial Results and Provides Corporate Update / $75.4 Million in First Quarter Net Sales; Conference Call Today at 4:30 p.m. Eastern Time | 45 | Marketwired | |
| SAN FRANCISCO, CA -- (Marketwired) -- 05/09/13 -- Medivation, Inc. (NASDAQ: MDVN) today provided a corporate update and reported its financial results for the first quarter ended March 31, 2013. Net... Mehr lesen zu: Medivation Reports First Quarter Financial Results and Provides Corporate Update / $75.4 Million in First Quarter Net Sales; Conference Call Today at 4:30 p.m. Eastern Time | ||||
| 07.05. | Goldman Sachs startet Medivation mit buy und Kursziel $68 | 58 | BörseGo | |
| Goldman Sachs startet Medivation mit buy und Kursziel $68
(© BörseGo AG 2013 - Autor: Tobias Krieg, Redakteur) Mehr lesen zu: Goldman Sachs startet Medivation mit buy und Kursziel $68 | ||||
| 06.05. | Medivation Announces Participation at Upcoming Investor Conferences | 44 | Marketwired | |
| SAN FRANCISCO, CA -- (Marketwired) -- 05/06/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conferences:
David Hung, M.D., president and chief executive... Mehr lesen zu: Medivation Announces Participation at Upcoming Investor Conferences | ||||
| 03.05. | Medivation Crosses Below its 10-day MA | 5 | SmarTrend | |
| 29.04. | MEDIVATION, INC. - 8-K, Current Report | 1 | SEC Filings | |
| 29.04. | Medivation Elects Wendy L. Yarno to Board of Directors | 49 | Marketwired | |
| SAN FRANCISCO, CA -- (Marketwired) -- 04/29/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that Wendy Yarno has been elected to the Company's Board of Directors. Ms. Yarno has over 26 years... Mehr lesen zu: Medivation Elects Wendy L. Yarno to Board of Directors | ||||
| 26.04. | Astellas, Medivation (MDVN) Receive Positive CHMP Opinion on XTANDI | 5 | StreetInsider.com | |
| 25.04. | Medivation Announces First Quarter 2013 Financial Results Teleconference on May 9, 2013 | 24 | Marketwired | |
| SAN FRANCISCO, CA -- (Marketwired) -- 04/25/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss first quarter 2013 financial results... Mehr lesen zu: Medivation Announces First Quarter 2013 Financial Results Teleconference on May 9, 2013 | ||||
| 24.04. | Medivation Bearish Moving Average Crossover Alert | 3 | SmarTrend | |
| 23.04. | MEDIVATION, INC. - 8-K, Departure of Directors or Certain Officers; Election of Directors; ... | 1 | SEC Filings | |
| 23.04. | Medivation Elects Dawn Graham to Board of Directors | 40 | Marketwired | |
| SAN FRANCISCO, CA -- (Marketwired) -- 04/23/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that Dawn Graham has been elected to the Company's Board of Directors. Ms. Graham joins Medivation... Mehr lesen zu: Medivation Elects Dawn Graham to Board of Directors | ||||
| 23.04. | Aragon Pharma's ARN-509 Is No Near-Term Threat to Medivation | 1 | Minyanville | |
| 22.04. | MEDIVATION, INC. - 8-K, Other Events | 2 | SEC Filings | |
| 18.04. | Is Medivation Still A Buy? | 4 | Motley Fool | |
| 05.04. | Pre-Market Analysis on Dendreon, ACADIA Pharma, Medivation, and Cell Therapeutics | 238 | PR Newswire | |
| LONDON, April 5, 2013 /PRNewswire/ --
Swiss pharmaceutical major Novartis AG recently lost a patent case related to its cancer drug in India. The development once again highlights that drug manufacturers... Mehr lesen zu: Pre-Market Analysis on Dendreon, ACADIA Pharma, Medivation, and Cell Therapeutics | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| MEDIGENE | 0,937 | -6,11 % | Medigene-Aktie feiert Studienergebnisse mit EndoTAG |
| EVOTEC | 2,818 | +0,07 % | Evotec-Aktie: Kursziel bei 3,50 Euro? |
| DENDREON | 3,08 | -1,66 % | Dendreon's Management Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript) |
| WILEX | 1,412 | +0,14 % | DGAP-HV: Wilex AG: Bekanntmachung der Einberufung -3- |
| MORPHOSYS | 35,76 | -0,45 % | DAX nur noch leicht im Minus: 3D Systems, Commerzbank, Daimler, Deutsche Bank, Deutsche Post, Google, Heideldruck, Klöckner & Co, Morphosys, ThyssenKrupp und QSC im Fokus |
